OPDIVO 10 mg/mL concentrate for solution for infusion.
BCT 1902
Phase 2 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion. for Early stage triple negative breast cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Early stage triple negative breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active